日出東方(603366.SH)擬2000萬元設立拉薩子公司 開發太陽能業務
格隆匯7月7日丨日出東方(603366.SH)公佈,因業務發展需要,公司擬以貨幣出資2000萬元人民幣,在西藏拉薩設立全資子公司西藏日出東方阿康清潔能源有限公司(暫定名)。
該公司經營範圍:太陽能集熱器的生產與銷售;太陽能、熱泵、工業餘熱、多能互補的清潔能源熱力工程的設計、施工與運維服務;熱力生產和供應;供氧工程設計、施工與運維服務;淨水工程設計與施工;光伏工程設計、施工與安裝;廚電及衞浴五金的銷售;勞務分包;工程諮詢服務;工程項目管理服務;貨物進出口。
本次設立全資子公司,在審批方面存在一定不確定性。新公司設立後,經營過程中可能面臨市場風險、經營管理等風險。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.